Halozyme Therapeutics
HALO
#2126
Rank
โ‚ฌ8.23 B
Marketcap
69,46ย โ‚ฌ
Share price
3.17%
Change (1 day)
52.23%
Change (1 year)

Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Volume in USD (price x number of shares), data since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚ฌ11.45 M-75.96%
2025โ‚ฌ47.66 M99.47%
2024โ‚ฌ23.89 M-6.29%
2023โ‚ฌ25.5 M-15.59%
2022โ‚ฌ30.2 M38.39%
2021โ‚ฌ21.82 M-6.23%
2020โ‚ฌ23.27 M-44.23%
2019โ‚ฌ41.74 M591.9%
2018โ‚ฌ6.03 M-64.48%
2017โ‚ฌ16.98 M-5.65%
2016โ‚ฌ17.99 M-13.05%
2015โ‚ฌ20.7 M-7.81%
2014โ‚ฌ22.45 M140.61%
2013โ‚ฌ9.33 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
โ‚ฌ0.14 Bโ‚ฌ0.27 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ67.22 Mโ‚ฌ0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ91.8 Mโ‚ฌ0.44 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ5.07 Mโ‚ฌ47.08 M๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
โ‚ฌ22.28 Mโ‚ฌ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ2.89 Mโ‚ฌ4.38 M๐Ÿ‡บ๐Ÿ‡ธ USA